Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Axsome Therapeutics (AXSM) Return on Assets (2022 - 2025)

Axsome Therapeutics' Return on Assets history spans 4 years, with the latest figure at 0.27% for Q4 2025.

  • For Q4 2025, Return on Assets rose 24.0% year-over-year to 0.27%; the TTM value through Dec 2025 reached 0.27%, up 24.0%, while the annual FY2025 figure was 0.29%, 21.0% up from the prior year.
  • Return on Assets for Q4 2025 was 0.27% at Axsome Therapeutics, up from 0.35% in the prior quarter.
  • Across five years, Return on Assets topped out at 0.27% in Q4 2025 and bottomed at 0.56% in Q2 2024.
  • The 4-year median for Return on Assets is 0.44% (2023), against an average of 0.44%.
  • The largest annual shift saw Return on Assets decreased -23bps in 2024 before it increased 24bps in 2025.
  • A 4-year view of Return on Assets shows it stood at 0.56% in 2022, then increased by 28bps to 0.4% in 2023, then fell by -26bps to 0.51% in 2024, then skyrocketed by 47bps to 0.27% in 2025.
  • Per Business Quant, the three most recent readings for AXSM's Return on Assets are 0.27% (Q4 2025), 0.35% (Q3 2025), and 0.4% (Q2 2025).